Biotricity (OTCMKTS:BTCY) Shares Down 17.7% – Time to Sell?

Biotricity Inc. (OTCMKTS:BTCY)’s share price dropped 17.7% during trading on Friday . The company traded as low as $0.2250 and last traded at $0.2750. Approximately 551,486 shares traded hands during trading, an increase of 840% from the average daily volume of 58,644 shares. The stock had previously closed at $0.3343.

Biotricity Price Performance

The stock has a market cap of $7.69 million, a price-to-earnings ratio of -1.62 and a beta of 1.33. The firm has a 50 day simple moving average of $0.48 and a two-hundred day simple moving average of $0.50.

Biotricity (OTCMKTS:BTCY) last announced its earnings results on Friday, November 14th. The company reported ($0.03) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.05. The business had revenue of $3.89 million during the quarter, compared to the consensus estimate of $3.90 million. On average, sell-side analysts expect that Biotricity Inc. will post -1.43 earnings per share for the current fiscal year.

Biotricity Company Profile

Biotricity (OTCMKTS:BTCY) is a medical device and digital health company specializing in remote cardiovascular monitoring and chronic disease management. The company’s flagship offering, the Bioflux system, integrates a wearable ECG patch with a cloud-based analytics platform to deliver real-time heart rhythm data and diagnostic insights. By combining wireless biosensors, mobile applications, and secure data transmission, Biotricity aims to simplify patient monitoring for healthcare providers and enhance early detection of arrhythmias and other cardiac events.

In addition to its core ambulatory ECG solution, Biotricity provides a suite of digital health products designed for broader chronic care management.